BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32181649)

  • 1. Optimizing the Biodistribution of Radiofluorinated Barbiturate Tracers for Matrix Metalloproteinase Imaging by Introduction of Fluorescent Dyes as Pharmacokinetic Modulators.
    Schwegmann K; Hohn M; Hermann S; Schäfers M; Riemann B; Haufe G; Wagner S; Breyholz HJ
    Bioconjug Chem; 2020 Apr; 31(4):1117-1132. PubMed ID: 32181649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards Optimized Bioavailability of
    Honold L; Austrup M; Faust A; Konken CP; Schwegmann K; Zinnhardt B; Daniliuc CG; Haufe G; Schäfers M; Kopka K; Hermann S
    Mol Imaging Biol; 2022 Jun; 24(3):434-443. PubMed ID: 34750717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofluorinated pyrimidine-2,4,6-triones as molecular probes for noninvasive MMP-targeted imaging.
    Breyholz HJ; Wagner S; Faust A; Riemann B; Höltke C; Hermann S; Schober O; Schäfers M; Kopka K
    ChemMedChem; 2010 May; 5(5):777-89. PubMed ID: 20373323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeled hydroxamate-based matrix metalloproteinase inhibitors: How chemical modifications affect pharmacokinetics and metabolic stability.
    Hugenberg V; Hermann S; Galla F; Schäfers M; Wünsch B; Kolb HC; Szardenings K; Lebedev A; Walsh JC; Mocharla VP; Gangadharmath UB; Kopka K; Wagner S
    Nucl Med Biol; 2016 Jul; 43(7):424-37. PubMed ID: 27179748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, (Radio)Synthesis, and in Vitro and in Vivo Evaluation of Highly Selective and Potent Matrix Metalloproteinase 12 (MMP-12) Inhibitors as Radiotracers for Positron Emission Tomography.
    Butsch V; Börgel F; Galla F; Schwegmann K; Hermann S; Schäfers M; Riemann B; Wünsch B; Wagner S
    J Med Chem; 2018 May; 61(9):4115-4134. PubMed ID: 29660282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracers for Fluorescence-Guided Surgery: How Elongation of the Polymethine Chain in Cyanine Dyes Alters the Pharmacokinetics of a Dual-Modality c[RGDyK] Tracer.
    Buckle T; van Willigen DM; Spa SJ; Hensbergen AW; van der Wal S; de Korne CM; Welling MM; van der Poel HG; Hardwick JCH; van Leeuwen FWB
    J Nucl Med; 2018 Jun; 59(6):986-992. PubMed ID: 29449447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntheses of Radioiodinated Pyrimidine-2,4,6-Triones as Potential Agents for Non-Invasive Imaging of Matrix Metalloproteinases.
    Breyholz HJ; Kopka K; Schäfers M; Wagner S
    Pharmaceuticals (Basel); 2017 May; 10(2):. PubMed ID: 28556793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.
    Breyholz HJ; Schäfers M; Wagner S; Höltke C; Faust A; Rabeneck H; Levkau B; Schober O; Kopka K
    J Med Chem; 2005 May; 48(9):3400-9. PubMed ID: 15857146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of PEGylated peptide probes conjugated with (18)F-labeled BODIPY for PET/optical imaging of MT1-MMP activity.
    Kondo N; Temma T; Deguchi J; Sano K; Ono M; Saji H
    J Control Release; 2015 Dec; 220(Pt A):476-483. PubMed ID: 26578437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of a novel fluorescent photoprobe for imaging matrix metalloproteinases.
    Faust A; Waschkau B; Waldeck J; Höltke C; Breyholz HJ; Wagner S; Kopka K; Heindel W; Schäfers M; Bremer C
    Bioconjug Chem; 2008 May; 19(5):1001-8. PubMed ID: 18396900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Evaluation of RYM1, a Matrix Metalloproteinase-Targeted Tracer for Imaging Aneurysm.
    Toczek J; Ye Y; Gona K; Kim HY; Han J; Razavian M; Golestani R; Zhang J; Wu TL; Jung JJ; Sadeghi MM
    J Nucl Med; 2017 Aug; 58(8):1318-1323. PubMed ID: 28360209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.
    Schrigten D; Breyholz HJ; Wagner S; Hermann S; Schober O; Schäfers M; Haufe G; Kopka K
    J Med Chem; 2012 Jan; 55(1):223-32. PubMed ID: 22118188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs).
    Rangasamy L; Geronimo BD; Ortín I; Coderch C; Zapico JM; Ramos A; de Pascual-Teresa B
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31426440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.
    Matusiak N; Castelli R; Tuin AW; Overkleeft HS; Wisastra R; Dekker FJ; Prély LM; Bischoff R; van Waarde A; Dierckx RA; Elsinga PH
    Bioorg Med Chem; 2015 Jan; 23(1):192-202. PubMed ID: 25438884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Conjugate of Pentamethine Cyanine and
    An FF; Kommidi H; Chen N; Ting R
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron Emission Tomography Imaging of Vessel Wall Matrix Metalloproteinase Activity in Abdominal Aortic Aneurysm.
    Toczek J; Gona K; Liu Y; Ahmad A; Ghim M; Ojha D; Kukreja G; Salarian M; Luehmann H; Heo GS; Guzman RJ; Ochoa Chaar CI; Tellides G; Hassab AHM; Ye Y; Shoghi KI; Zayed MA; Gropler RJ; Sadeghi MM
    Circ Cardiovasc Imaging; 2023 Jan; 16(1):e014615. PubMed ID: 36649454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical models.
    Kasten BB; Jiang K; Cole D; Jani A; Udayakumar N; Gillespie GY; Lu G; Dai T; Rosenthal EL; Markert JM; Rao J; Warram JM
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1412-1426. PubMed ID: 31773232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Dual-Modality Linker Enables Site-Specific Conjugation of Antibody Fragments for
    Zettlitz KA; Waldmann CM; Tsai WK; Tavaré R; Collins J; Murphy JM; Wu AM
    J Nucl Med; 2019 Oct; 60(10):1467-1473. PubMed ID: 30877181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.
    Hugenberg V; Breyholz HJ; Riemann B; Hermann S; Schober O; Schäfers M; Gangadharmath U; Mocharla V; Kolb H; Walsh J; Zhang W; Kopka K; Wagner S
    J Med Chem; 2012 May; 55(10):4714-27. PubMed ID: 22540974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of Novel Nuclear Medical Imaging Probes for Quantification of Matrix Metalloproteinases in Diseases].
    Kondo N
    Yakugaku Zasshi; 2020; 140(1):7-13. PubMed ID: 31902888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.